International Case Reports Journal (ISSN: 2770-9647) | Volume 5, Issue 1 | Research Article | Open Access
Wang Yuqin*
Jing Xihui1, Yan Chunmei1, Zi Heping1, Shi Xiaoxiao2, Wang Yuqin2
1Department of Pediatrics, Yulin Hospital of Traditional Chinese Medicine, China
2Department of Nursing, Yulin Hospital of Traditional Chinese Medicine, China
*Correspondence to: Wang Yuqin
Fulltext PDFMycoplasma Pneumoniae (MP) is the primary pathogen of acquired pneumonia in children, accounting for approximately 5%-30% of all acquired pneumonia pathogens in pediatric populations. Its transmission routes are primarily droplet transmission and direct contact with the pathogen. The incubation period ranges from 7 to 21 days, during which the pathogen remains infectious until symptom resolution, which may take several weeks. In recent years, refractory and macrolide-resistant Mycoplasma pneumoniae infections have become increasingly prevalent. The nursing philosophy for pediatric Mycoplasma Pneumonia (MPP) has evolved from traditional symptomatic support to a more refined, evidence-based, individualized, and comprehensive approach. This article systematically reviews the optimization and upgrading of core nursing measures, provides an in-depth analysis of research hotspots and latest advancements in critical early warning, medication management, complication control, nutritional and psychological support, and continuous care, summarizes the key characteristics of current nursing models, and outlines future development directions, offering reference for clinical nursing practice.
Children; Mycoplasma pneumonia; Nursing progress; Severe warning; Continuous care; Complication nursing
Xihui J, Chunmei Y, Heping Z, Xiaoxiao S, Yuqin W. Research Progress of Mycoplasma Pneumonia in Children. Int Case Rep Jour. 2026;5(1):1-6.